Literature DB >> 15334702

An unusual presentation of "silent" disseminated pancreatic neuroendocrine tumor.

Dragomir Marisavljevic1, Natasa Petrovic, Nikola Milinic, Vesna Cemerikic, Miodrag Krstic, Olivera Markovic, Dragoljub Bilanovic.   

Abstract

To present a patient diagnosed with pancreatic carcinoid that was extremely rare and produced an atypical carcinoid syndrome. We reported a 58-year old male patient who presented with long standing, prominent cervical lymphadenopathy and occasional watery diarrhea. Pathohistological and immunohistochemical examination of lymph node biopsy showed a metastatic neuroendocrine tumor, which was histological type A of carcinoid (EMA+, cytokeratin+, CEA-, NSE+, chromogranin A+, synaptophysin+, insulin-). Bone marrow biopsy showed identical findings. Primary site of the tumor was pancreas and diagnosis was made according to cytological and immunocytochemical analysis of the tumor cells obtained with aspiration biopsy of pancreatic mass (12 mm in diameter) under endoscopic ultrasound guidance. However, serotonin levels in blood and urine samples were normal. It is difficulty to establish the precise diagnosis of a "functionally inactive" pancreatic carcinoid and aspiration biopsy of pancreatic tumor under endoscopic ultrasound guidance can be used as a new potent diagnostic tool.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334702      PMCID: PMC4572134          DOI: 10.3748/wjg.v10.i19.2919

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

Review 1.  Carcinoid tumors.

Authors:  M H Kulke; R J Mayer
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

2.  Gastrointestinal carcinoids: characterization by site of origin and hormone production.

Authors:  M W Onaitis; P M Kirshbom; T Z Hayward; F J Quayle; J M Feldman; H F Seigler; D S Tyler
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 3.  Cardiovascular complications of malignant carcinoid disease.

Authors:  A S Anderson; D Krauss; R Lang
Journal:  Am Heart J       Date:  1997-10       Impact factor: 4.749

4.  Neuroendocrine tumors of the pancreas.

Authors:  S Varshney; C D Johnson
Journal:  Indian J Gastroenterol       Date:  2000 Oct-Dec

5.  Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.

Authors:  K O Shebani; W W Souba; D M Finkelstein; P C Stark; K M Elgadi; K K Tanabe; M J Ott
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

Review 6.  Pancreatic endocrine tumors: recent advances.

Authors:  R T Jensen
Journal:  Ann Oncol       Date:  1999       Impact factor: 32.976

Review 7.  Carcinoid of the pancreas: clinical characteristics and morphological features.

Authors:  C A Maurer; H U Baer; T H Dyong; E Mueller-Garamvoelgyi; H Friess; C Ruchti; J C Reubi; M W Büchler
Journal:  Eur J Cancer       Date:  1996-06       Impact factor: 9.162

Review 8.  Tumor markers in neuroendocrine tumors.

Authors:  B Eriksson; K Oberg; M Stridsberg
Journal:  Digestion       Date:  2000       Impact factor: 3.216

9.  Carcinoid Tumors of the Gut.

Authors: 
Journal:  Cancer Control       Date:  1997-01       Impact factor: 3.302

Review 10.  Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management.

Authors:  A I Vinik; N Thompson; F Eckhauser; A R Moattari
Journal:  Acta Oncol       Date:  1989       Impact factor: 4.089

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.